The Addiction Severity Index (ASI) Across Cultures TRI science addiction 2005 NIDA International Forum June 17th, 2005 Workshop II - The Ireland Room B.

Slides:

Advertisements

Similar presentations

Programme: 145 sessions & social events

Advertisements

Substance Use: Substance use comparisons included lifetime and past 30 day use (Figure 3) and lifetime use. For past 30 day use, more men reported heroin.

Section 17: Treatment Planning. 2 Icebreaker How do you define treatment planning?

Comparison of recreational marijuana users in three nations Monisha Jayakumar, MPH PhD Program in Maternal and Child Health Johns Hopkins Bloomberg School.

Hunter centre for strathclyde Global Entrepreneurship Monitor Scotland 2002 Jonathan Levie Wendy Brown Laura Galloway.

EYES ON THE FUTURE Be part of the Solution Come to debate and innovate ! 12 th EFTC CONGRES The Hague, The Netherlands 2 nd – 5 th June 2009.

Section 13: Assessment – Addiction Severity Index (ASI)

Slide 1 of 20 Overview of National Treatment Outcome Studies Charts Prepared & Released for Public Use by Dwayne Simpson (TCU), Robert Hubbard (NDRI-NC),

© Lloyd’s Regional Watch Content Guide CLICK ANY BOX AMERICAS IMEA EUROPE ASIA PACIFIC.

Drug Abuse Research in the Middle East: An Exercise in Cooperation Richard Rawson, Ph.D. UCLA ISAP Los Angeles, Calif USA

Nathalie Moreau Anne Hublet Alcohol use in year olds in Belgium. Results from the Health Behaviour in School-aged Children.

Does Case Management Improve Linkage to Substance Abuse Treatment? By Erin.

"Meeting Challenges: Trying to Stay One Step Ahead" Steve Hanson Associate Commissioner Treatment & Practice Innovation.

Substance Abuse Treatment. PROFILE OF A DRUG ABUSER  MOST PEOPLE IN TREATMENT ARE BETWEEN YEARS OF AGE  MANY DRUG ABUSERS SUFFER FROM MENTAL HEALTH.

State of Mental Health in Ukraine: 2002 Evelyn J. Bromet September, 2007.

WORK PACKAGE TREATMENT CHALLENGES Dr.Thomas Legl Member of Executive Committee EURO –TC Director Kur- und Gesundheitszentrum Knappenhof/Austria ICAA,,

SUBSTANCE USE DISORDERS GENERAL METHODS OF TREATMENT Inpatient Detoxification and Rehabilitation Outpatient Individual, Couple, or Family Counseling Self-help.

Factors that Influence Retention in Greek Therapeutic Communities Erianna Daliani MSc (Gerasimos Papanastasatos) KETHEA Research Dept. 11th European Conference.

Audrey J. Brooks, PhD University of Arizona CA-AZ node.

ILLINOIS STATEWIDE TREATMENT OUTCOMES PROJECT. Illinois Statewide Treatment Outcomes Project Largest evaluation of treatment outcomes by the State to.

International Outcomes of Learning in Mathematics and Problem Solving: PISA 2003 Results from the U.S. Perspective Commissioner Robert Lerner National.

Impact of Inhalant Use in Venezuela Elvia Amesty, MGSc Jose Felix Ribas Foundation.

MARRCH 2007 Annual Conference October 30, 2007 Addressing “Paperwork Burden” Transforming Data into useful Information for Counselors and Clients Deni.

METHODS Sample n=245 Women, 24% White, 72% Average age, 36.5 Never married, 51% Referral Sources (%) 12-Month DSM-IV Substance Dependence Prior to Entering.

Journal Club Alcohol, Other Drugs, and Health: Current Evidence May–June 2012.

Chapter 3 Addictions: Theory and Treatment. Drug Addiction Behavioral pattern of drug use Overwhelming involvement Securing of its supply Tendency to.

Obtaining housing associated with achieving abstinence after detoxification in adults with addiction Tae Woo Park, Christine Maynié-François, Richard Saitz.

An overview of European trends and developments Roland Simon ECAD Meeting 2011, Varna.

Delivery Systems for Substance Abuse Treatment An International Conference Istanbul, Turkey September 5-7, 2005 Sponsoring Organizations: USIP UNODC, UCLA.

Countries of Europe France Spain Italy Germany Which country is this?

Erik Iversen, Norway Workshop at the annual TDI expert meeting EMCDDA, Lisbon 25 September 2006 Data Coverage Assessment The Bergen Clinics Foundation,

WORK PACKAGE TREATMENT CHALLENGES Dr.Thomas Legl Member of Executive Committee EURO –TC Director Kur- und Gesundheitszentrum Knappenhof/Austria ICAA,,

Arash Ghodousi Addiction Therapy 2015 Florida, USA August 03-08, 2015.

Increased exposure to an HIV risk reduction protocol associated with a reduction in drug abuse severity Louise F. Haynes 1 ; Rickey E. Carter 1 ; Amy E.

1 National Outcomes and Casemix Collection Training Workshop Adult Ambulatory.

LAWRENCE CAMPUS WEST 100 FEDERAL CITY ROAD LAWRENCEVILLE, NJ.

Participants were recruited from 6 drug free, psychosocial treatment (PT) and 5 methadone maintenance (MM) programs (N = 628) participating in a NIDA Clinical.

France Belgium Italy South Africa USA UK Australia New Zealand Israel Austria Norway Ireland Den- mark Finland Spain Canada Nether- lands Sweden Switzer-

Linda Montanari, Buenos Aires, October 2003 CICAD/OAS, Demand Reduction Experts Group Meeting The Information System on Treatment Demand in EU EMCDDA.

Introduction Introduction Alcohol Abuse Characteristics Results and Conclusions Results and Conclusions Analyses comparing primary substance of abuse indicated.

Buprenorphine and the NIDA CTN: Research to Practice Walter Ling & Richard Rawson ISAP/UCLA XIII World Congress of Psychiatry September 14, 2005 Cairo,

Module 1 General introduction to substitution treatment.

Introduction Results and Conclusions Categorical group comparisons revealed no differences on demographic or social variables. At admission to treatment,

Slide 1 of 19 National Treatment Retention Findings from DATOS Charts Prepared & Released for Public Use by Dwayne Simpson (TCU), Robert Hubbard (NDRI-NC),

Treatment for Substance Abusers in the Therapeutic Community.

Addiction Treatment in Israel: An Overview of Services Provision Iris Mordecovitch, MSW.

Table 1. Prediction model for maximum daily dose of buprenorphine-naloxone in a 12-week treatment condition Baseline Predictors Maximum Daily Dose Standardized.

METHADONE VS. NON-METHADONE PATIENTS IN A THERAPEUTIC COMMUNITY: TEST OF EQUIVALENCY James L. Sorensen 1,2, S. Andrews 1,2, K. L. Delucchi 1,3, B. Greenberg.

Health care trajectories and medication consumption of substance users in treatment : linking TDI and IMA databases (Belgium) De Ridder Karin, Antoine.

Creating A Cooperative Drug Abuse Research Network in the Middle East Richard A. Rawson Albert Hasson UCLA Integrated Substance Abuse Programs Los Angeles,

2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 13: International Comparisons.

Ten Years of Pharmacotherapy Trials in the CTN: An Overview.

Hello Around the World ! Europe France Everyone in France speaks French. Bonjour (BONE-zhure) Example Slide.

The (IMG) Systems for Comparative Analysis of Microbial Genomes & Metagenomes: N America: 1,180 Europe: 386 Asia: 235 Africa: 6 Oceania: 81 S America:

What the National Institute on Drug Abuse’s Clinical Trials Network Can Do for You? Major Findings from Medication Trials and Implications for Community-Based.

Largest evaluation of treatment outcomes by the State to date 1,890 adult clients recruited from 40 treatment programs across the state Three levels of.

Country EPS-12 Total (with ICPS) Hungary7979 Germany5559 Romania3841 Ukraine2527 United Kingdom1930 Finland1842 France1616 Italy1616 Poland1313 Switzerland1314.

The Mission of CERN  Push back  Push back the frontiers of knowledge E.g. the secrets of the Big Bang …what was the matter like within the first moments.

Introduction Results and Conclusions Numerous demographic variables were found to be associated with treatment completion. Completers were more likely.

Global Powered Lawn Mower Market to Market Size, Growth, and Forecasts in Nearly 70 Countries “This comprehensive publication enables readers the.

Global Printing Ink Market to Market Size, Growth, and Forecasts in Over 70 Countries “This comprehensive publication enables readers the critical.

Global Aluminium Pipe and Tube Market to 2018 (Market Size, Growth, and Forecasts in Nearly 60 Countries) Published Date: Jul-2014 Reports and Intelligence.

GLOBAL ENTREPRENEURSHIP MONITOR Funding Fair Wednesday 25 th May 2016.

Medication Adherence and Substance Abuse Predict 18-Month Recidivism among Mental Health Jail Diversion Program Clients Elizabeth N. Burris 1, Evan M.

Liver cirrhosis mortality in European countries II Working Meeting on Adult Premature Mortality in European Union Warsaw, October 2006.

Ch. 17 Preventing Drug Abuse Section 4 Choosing to be Drug Free.

outpatient drug or alcohol clinic, mental health or community health center, private mental health professional, in-home counseling or crisis services,

“Integrating Microbial Knowledge into Human Life”

The relationship between incarceration and opioid addiction treatment

Electrification business

Presentation transcript:

The Addiction Severity Index (ASI) Across Cultures TRI science addiction 2005 NIDA International Forum June 17th, 2005 Workshop II - The Ireland Room B Thanks to NIDA: Steve Gust & Erin Winstanley

The Addiction Severity Index (ASI) Across Cultures TRI science addiction Today’s Presenters:

Selection, Modification and Inter-rater Reliability on the use of the ASI in Egypt Sample: Adult Inpatient Hospital Program in Cairo Nasser Loza, Egypt TRI science addiction

Elaborating and using the ASI across different national realities and treatment conditions – The EuropASI in Greek Treatment Programmes Sample: Adults in 6 Drug-Free Therapeutic Communities in Greece Gerasimos Papanastasatos, Greece TRI science addiction

Understanding the Israeli addict population – ASI profiles of former Soviet Union and native Israeli opiate abusers Sample – Adults in detoxification, day treatment and methadone maintenance programs Richard Isralowitz, Israel TRI science addiction

Incorporating the ASI: Exploring assessment and outcomes in a residential treatment facility in Northern Ireland Sample: Adult Residential Treatment Facility in Northern Ireland Debra Wilson & Pauline Murnin, Ireland TRI science addiction

The Brazilian experience on the implementation of the ASI – where are we right now? Sample: Adult Cocaine HIV clinics in Brazil and a Validity Study of the ASI 6 Flavio Pechansky, Brazil TRI science addiction

Experiences using the ASI in different countries. and… Richard Rawson, USA TRI science addiction

ASI International Use and Data from 10 Countries Deni Carise, USA TRI science addiction

Introduction TRI science addiction In addition to those presenting here, researchers and clinicians in the following countries have used the ASI: The ASI has been translated and modified for use in many countries.

Introduction Countries TRI science addiction Thailand Scotland Hungary Ukraine The Netherlands Sweden Iran Pakistan Spain Italy Belgium Canada The Caribbean Chile Guatemala Morocco Tunisia Portugal Russia Norway

Introduction Deni’s Presentation TRI science addiction Today, data are presented from the US Drug Evaluation Network System and various samples in: Belgium Brazil GreeceIreland Italy Norway RussiaScotland Sweden

Data Sets TRI science addiction

Introduction TRI science addiction Data Sets USA Deni Carise & A. Thomas McLellan 8,479 patients from 14 inpatient/ residential, 4 methadone maintenance and 18 out-patient treatment programs BrazilFlavio Pechansky & Felix Kessler 193 cocaine-dependent clients from 3 HIV Clinics

Introduction TRI science addiction Data Sets GreeceGerasimos Papanastasatos & Erianna Daliani 500 clients from 4 residential and 2 OP programs Ireland Debra Wilson & Pauline Murnin 162 clients from 1 inpatient program

Introduction Data Sets Belgium 1 Joke De Wilde 117 Clients from 4 adult residential drug-free TC’s Belgium 2 Veerle Raes 3,712 clients from a large drug addiction treatment program

ItalyJoke De Wilde 101 clients from 5 adult residential drug-free TC’s Norway Edle Ravndal 482 clients from 10 IP, 4 MM, 3 OP youth and 4 youth “collectives”. RussiaEvgeny Krupitsky 332 clients from 1 adult hospital detox & treatment program. Data Sets TRI science addiction

ScotlandRowdy Yates 134 clients from 1 adult OP drug treatment program. Sweden Jonas Larsson, David Oberg & Bjorn Sallmen 201 prisoners from 16 SA prison-based treatment programs Data Sets TRI science addiction

Data Sets TRI science addiction

AgeAge GenderGender Alcohol & Drug Composite scoresAlcohol & Drug Composite scores Days heavy drinkingDays heavy drinking Days used marijuanaDays used marijuana Days used cocaineDays used cocaine TRI science addiction Data Presented:

Medical, Psychiatric, Family and Legal: Composite ScoresComposite Scores Days problemsDays problems Days conflictsDays conflicts Percent reporting symptomsPercent reporting symptoms Illegal behaviorIllegal behavior Employment variablesEmployment variables TRI science addiction Data Presented:

International Data Sample NAge (SD)% Male Belgium (6)84 Brazil Greece50026 (5)84 Ireland16241 (10)69 Italy10128 (4)88 Norway48231 (8)67 Russia33223 (0)74 Scotland13427 (6)68 Sweden20136 (11)95 U.S.A (11)66

International Data – Drug & Alcohol Alc. CSDrink 5+ Drg. CSCocaineCannabis Belgium 1.11 (.19)2 (5).17 (.13)1 (5)5 (8) Brazil.25 (.20)10 (9).19 (.10)13 (10)21 (11) Greece-0 (2).21 (.11)0 (2)2 (6) Ireland.67 (.26)16 (10).07 (.14)0 (1)3 (8) Italy.20 (.27)6 (11).26 (.17)2 (6)8 (12) Norway.08 (.14)2 (6).31 (.13)0 (3)10 (12) Russia.28 (.00)-.08 (.01)-- Scotland.07 (.18)4 (9).43 (.09)1 (4)16 (13) Sweden.52 (.28)13 (12).05 (.09)1 (4)2 (7) U.S.A..21 (.26)3 (7).12 (.13)3 (7)2 (6)

International Data – Medical & Psychiatric Med. CS Med. Prob. Psy. CS% Dep.Psy. Prob. Belgium 1.35 (.32)10 (12).49 (.24)3813 (12) Brazil.24 (.28)12 (9).23 (.22)2115 (11) Greece.21 (.29)4 (8).21 (.18)219 (11) Ireland.40 (.41)11 (13).48 (.26)5918 (13) Italy.17 (.23)2 (6).38 (.26)279 (12) Norway.25 (.32)8 (12).27 (.23)3311 (13) Russia.23 (.01)-.25 (.01)-- Scotland.34 (.39)8 (5).32 (.26)6411 (12) Sweden.34 (.37)10 (14).24 (.21)289 (13) U.S.A..17 (.30)5 (10).19 (.23)308 (11)

International Data – Family & Legal Fam. CSConflictsLeg. CSIllegal ActWorkEmp. Prob. Belgium 1.20 (.22)2 (6).34 (.23)2 (7)2 (5)4 (8) Brazil.24 (.21)10 (10).12 (.17)8 (9)22 (9)9 (10) Greece.34 (.20)5 (9)-1 (5)3 (8)5 (13) Ireland.29 (.26)7 (11).09 (.19)0 (3)4 (8)6 (11) Italy.36 (.26)7 (11).30 (.29)6 (10)4 (9)1 (1) Norway.16 (.19)4 (9).31 (.28)10 (13)5 (10)3 (9) Russia.41 (.01)-.17 (.02)--- Scotland.38 (.23)6 (8).40 (.25)17 (13)1 (5)9 (11) Sweden.18 (.20)3 (8).28 (.13)4 (10)5 (10)8 (13) U.S.A..16 (.21)3 (7).18 (.21)1 (4)8 (10)8 (12)

Belgium 2 Veerle Raes Data collected ,712 interviews 383 Inpatient; 3,329 Outpatient All collected from a large “illegal drug addiction treatment program” (may under-represent alcohol use). Larger Belgium Data Set TRI science addiction

USA vs. Belgium Data by Modality U.S.A. (IP)Belgium 2 (IP)U.S.A. (OP)Belgium 2 (OP) Sample N 3, ,8853,329 Age (SD) 36 (11)25 (6)33 (10)27 (7) % Male Alc. CS.33 (.27).1 (.2).16 (.23).1 (.1) Drink 5+ 5 (9)2 (5)2 (6)3 (6) Drg. CS.11 (.14).2 (.1).09 (.11).2 (.1) Cocaine 3 (8)2 (5)2 (6)2 (5) Cannabis 2 (6)4 (8)2 (6)11 (12)

USA vs. Belgium Data by Modality U.S.A. (IP)Belgium 2 (IP)U.S.A. (OP)Belgium 2 (OP) Med. CS.16 (.29).3 (.3).15 (.28).2 (.3) Med. Prob. 4 (9)8 (11)5 (10)7 (11) Psy. CS.20 (.24).3 (.2).16 (.22).2 (.2) % Dep Psy. Prob.8 (12)14 (12)6 (11)10 (11) Fam. CS.15 (.21).3 (.2).13 (.20).1 (.2) Conflicts3 (8) 2 (7)2 (6) Leg. CS.20 (.22).3 (.2).18 (.20).2 (.2) Illegal Act1 (5)3 (7)1 (4)1 (5) Work8 (10)1 (5)9 (11)8 (11) Emp. Prob. 8 (12)3 (8)9 (12)5 (10)

Conclusions TRI science addiction

Conclusions TRI science addiction Data presented just for discussion - No conclusions please! Data were collected from too many different locations (prisons, HIV clinics, in patient, outpatient treatment programs) and from too many different samples (opiate only users, primary alcohol users, an all inpatient sample, an outpatient only sample, etc.) for valid comparisons to be made.

Limitations TRI science addiction

The End TRI science addiction